loading

Intra Cellular Therapies Inc Stock (ITCI) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
9.66%
144.87
132.10 126.17 110.79 95.31
Operating Expenses
0.23%
165.82
166.20 155.89 157.97 143.70
Benefits Costs and Expenses
159.75
- - - -
Costs And Expenses
3.88%
159.75
166.20 155.89 157.97 143.70
Operating Income/Loss
38.55%
-20.95
-34.10 -29.71 -47.18 -48.39
Income/Loss From Continuing Operations Before Tax
111.27%
-14.89
132.10 -24.21 -42.65 -44.04
Income Tax Expense/Benefit
19.87%
0.359
0.448 0.043 0.135 0.01
Income/Loss From Continuing Operations After Tax
46.65%
-15.25
-28.58 -24.26 -42.78 -44.05
Net Income/Loss
46.65%
-15.25
-28.58 -24.26 -42.78 -44.05
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
71,086%
96.88
0.1361 96.14 95.95 95.13
Diluted Average Shares
71,086%
96.88
0.1361 96.14 95.95 95.13
Basic Earnings Per Share
46.67%
-0.16
-0.30 -0.25 -0.45 -0.46
Diluted Earnings Per Share
46.67%
-0.16
-0.30 -0.25 -0.45 -0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$10.90
price down icon 0.46%
$150.51
price down icon 0.46%
$17.29
price up icon 0.46%
$90.90
price up icon 0.51%
$11.97
price down icon 0.50%
Cap:     |  Volume (24h):